PP
AMGN icon

PagnatoKarp Partners’s Amgen AMGN Stock Holding History

PagnatoKarp Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,079
Closed -$421K – 9
2020
Q1 		$421K Sell
2,079
-22
-1% -$4.8K 0.1% 101
2019
Q4 		$506K Buy
2,101
+62
+3% +$13.7K 0.09% 106
2019
Q3 		$395K Buy
2,039
+37
+2% +$7.1K 0.08% 128
2019
Q2 		$369K Sell
2,002
-51
-2% -$9.13K 0.08% 130
2019
Q1 		$390K Sell
2,053
-24
-1% -$4.58K 0.09% 117
2018
Q4 		$404K Sell
2,077
-24
-1% -$4.68K 0.09% 97
2018
Q3 		$436K Buy
2,101
+25
+1% +$4.93K 0.13% 100
2018
Q2 		$383K Buy
+2,076
New +$367K 0.12% 96

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PagnatoKarp Partners's AMGN Position: Q2 2020 in Review

PagnatoKarp Partners sold out of Amgen (AMGN) in Q2 2020, closing a stake of 2,079 shares — an estimated $421K sold.

PagnatoKarp Partners first reported a position in AMGN in Q2 2018 and held it in 8 quarters. The position peaked at $506K in Q4 2019. 2,091 funds tracked by Wall St. Rank hold AMGN as of Q2 2020.

  • PagnatoKarp Partners reported no remaining Amgen position as of Q2 2020 after selling out during the quarter.
  • PagnatoKarp Partners sold 2,079 Amgen shares in Q2 2020, an estimated $421K.
  • PagnatoKarp Partners first reported a position in Amgen in Q2 2018 and held it in 8 quarters.
  • PagnatoKarp Partners's Amgen position peaked at $506K in Q4 2019.
  • 2,091 funds tracked by Wall St. Rank held Amgen as of Q2 2020.

Based on PagnatoKarp Partners's 13F filing for Q2 2020.